Literature DB >> 9741528

Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging.

J Bremerich1, M F Wendland, H Arheden, R Wyttenbach, D W Gao, J P Huberty, M W Dae, C B Higgins, M Saeed.   

Abstract

OBJECTIVES: The purpose of this study was to measure the accumulation of labeled albumin and to visualize its distribution pattern in reperfused infarcted myocardium as a function of time between onset of reperfusion and administration of the tracer.
BACKGROUND: Myocardial microvascular injury leads to leakage of albumin from the intravascular space. Quantitative measurements of GdDTPA-albumin with inversion recovery echoplanar imaging (IR-EPI) may allow noninvasive monitoring of microvascular injury.
METHODS: After 1 h of coronary artery occlusion, 56 rats were injected with GdDTPA-albumin or 123I-GdDTPA-albumin either immediately before reperfusion or 1/2, 1 or 24 h after reperfusion. GdDTPA-albumin in blood, normal myocardium and reperfused infarction was dynamically measured with IR-EPI during 1 h postinjection (PI). Autoradiograms were obtained at 15 min PI. Accumulation of labeled albumin in myocardium was expressed as the ratio of myocardial to blood content.
RESULTS: In normal myocardium, the ratio of changes of relaxation rate-ratio (deltaR1-ratio) was 0.12+/-0.01 and did not change over 1 h. In reperfused infarction, however, the deltaR1-ratio increased after administration. Animals given GdDTPA-albumin before reperfusion exhibited fastest accumulation (deltaR1-ratio 15 min PI: 0.56+/-0.03) and essentially homogeneous distribution. The accumulation was slower when administered at 1/2, 1 and 24 h after reperfusion (deltaR1-ratios 15 min PI: 0.39+/-0.03; 0.31+/-0.04; 0.16+/-0.01; p < 0.001 compared to administration before reperfusion). Moreover, the tracer accumulated predominantly in the periphery of the injury zone.
CONCLUSIONS: Amount and distribution pattern of labeled albumin in reperfused infarction are modulated by duration of reperfusion. The accumulation of GdDTPA-albumin can be quantified by IR-EPI. Thus, IR-EPI may be useful to noninvasively monitor myocardial microvascular injury in reperfused infarction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741528     DOI: 10.1016/s0735-1097(98)00315-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside.

Authors:  Pierre Croisille; Didier Revel; Maythem Saeed
Journal:  Eur Radiol       Date:  2006-04-22       Impact factor: 5.315

2.  Collateral circulation formation determines the characteristic profiles of contrast-enhanced MRI in the infarcted myocardium of pigs.

Authors:  Jian Wang; Bo Xiang; Hung-yu Lin; Hong-yu Liu; Darren Freed; Rakesh C Arora; Gang-hong Tian
Journal:  Acta Pharmacol Sin       Date:  2015-03-23       Impact factor: 6.150

3.  Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty.

Authors:  Francesco Bellandi; Mario Leoncini; Mauro Maioli; Anna Toso; Michela Gallopin; Roberto Piero Dabizzi
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

4.  Coronary No-reflow Phenomenon.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

Review 5.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 6.  Macromolecular and dendrimer-based magnetic resonance contrast agents.

Authors:  Ambika Bumb; Martin W Brechbiel; Peter Choyke
Journal:  Acta Radiol       Date:  2010-09       Impact factor: 1.990

Review 7.  Reperfusion revisited: beyond TIMI 3 flow.

Authors:  J P Gassler; E J Topol
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

8.  Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents.

Authors:  L M Riou; A Broisat; C Lartizien; M C Toufektsian; S Maitrejean; M Janier; G Vanzetto; D Fagret; C Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-27       Impact factor: 9.236

9.  Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study.

Authors:  Antonello Zoni; Peter Knoll; Tiziano Gherli
Journal:  Heart Int       Date:  2006-05-28

10.  Differential MR delayed enhancement patterns of chronic myocardial infarction between extracellular and intravascular contrast media.

Authors:  Jian Wang; Bo Xiang; Hung Yu Lin; Hongyu Liu; Darren Freed; Rakesh C Arora; Ganghong Tian
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.